Titan Pharmaceuticals Inc.
TTNP | NASDAQ
$2.34
-$0.30 (-11.36%)
At close: Dec 16, 2025, 1:46 PM ET
Fiscal Quarter Period Ending | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 | Q4 2020 Dec 31, 2020 | Q3 2020 Sep 30, 2020 | Q2 2020 Jun 30, 2020 | Q1 2020 Mar 31, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | 10K | n/a | n/a | n/a | 81K | 4K | 1K | 98K | 51K | 4K | 150K | 192K | 135K | 264K | 445K | 682K | 1.06M | 1.12M | 1.33M | 1.34M |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 3K | 27K | 442K | 43K | n/a | 932K | 51K | 52K | 53K | 1.19M | 89K | 110K | 2.05M | 683K | 228K | 171K |
Gross Profit | n/a | n/a | n/a | n/a | 5K | n/a | -3K | -2K | 78K | -23K | -441K | 55K | 51K | -928K | 99K | 140K | 82K | -929K | 356K | 572K | -988K | 437K | 1.1M | 1.17M |
Operating Income | -448K | -777K | -657K | -534K | -666K | -754K | -2.07M | -1.06M | -1.93M | -2.06M | -1.59M | -1.7M | -2.61M | -2.64M | -2.44M | -2.54M | -2.49M | -1.91M | -2.33M | -2.63M | 5.93M | -4.67M | -4.38M | -4.23M |
Interest Income | n/a | n/a | n/a | n/a | -1K | n/a | n/a | 1K | n/a | n/a | 7K | 22K | 27K | 21K | 5K | n/a | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -430K | -803K | -689K | -563K | -790K | -763K | -2.09M | -1.06M | -1.97M | -338K | -1.59M | -1.68M | -2.57M | -2.64M | -2.46M | -2.54M | -2.54M | -1.92M | -1.68M | -2.64M | 7.75M | -1.22M | -4.64M | -5.58M |
Net Income | -430K | -803K | -689K | -563K | -790K | -763K | -2.09M | -1.06M | -1.97M | -338K | -1.59M | -1.65M | -2.57M | -2.64M | -2.48M | -2.54M | -2.54M | -1.92M | -1.68M | -2.64M | -3.09M | -4.93M | -4.64M | -5.58M |
Selling & General & Admin | 448K | 777K | 657K | 534K | 666K | 754K | 2.07M | 1.06M | 1.44M | 1.64M | 1.23M | 1.23M | 1.29M | 1.81M | 1.62M | 1.32M | 1.65M | 979K | 1.04M | 1.33M | -4.34M | 3.55M | 3.47M | 3.11M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 487K | 424K | 442K | 561K | 1.44M | 932K | 974K | 1.41M | 976K | 1.19M | 1.65M | 1.88M | 70K | 1.56M | 2.01M | 2.28M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2K | n/a | 2K | -5K | -98K | -70K | -16K | -25K | -1K | -54K | -7K | -16K | -8K | 1.95M | -12K | -7K | n/a |
Operating Expenses | 448K | 777K | 657K | 534K | 666K | 754K | 2.07M | 1.06M | 1.93M | 2.06M | 1.59M | 1.7M | 2.66M | 2.65M | 2.59M | 2.73M | 2.62M | 2.17M | 2.68M | 3.2M | -4.27M | 5.11M | 5.48M | 5.39M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 33K | 11K | n/a | n/a | n/a | n/a | n/a | 1K | n/a | n/a | 1K | 1K | 51K | 246K | 250K | 222K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2K | -3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.01M | n/a | n/a | n/a | n/a | n/a | n/a | 1.83M |
Cost & Expenses | 448K | 777K | 657K | 534K | 666K | 754K | 2.07M | 1.06M | 1.93M | 2.06M | 1.59M | 1.7M | 2.66M | 2.65M | 2.59M | 2.73M | 2.62M | 2.17M | 2.77M | 3.31M | -4.88M | 5.79M | 5.71M | 5.56M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 234K | 243K | 9K |
Shares Outstanding (Basic) | 1K | 1.4M | 1.07M | 914K | 899K | 914K | 914K | 853K | 781.5K | 750.8K | 750.8K | 750.8K | 711.25K | 731.45K | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 3.26M | 3.17M | 2.76M |
Shares Outstanding (Diluted) | 1K | 1.4M | 1.07M | 914K | 899K | 914K | 914K | 853K | 781.5K | 750.8K | 750.8K | 750.8K | 711.25K | 731.45K | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 3.26M | 3.17M | 2.76M |
EPS (Basic) | -430 | -0.57 | -0.65 | -0.62 | -0.88 | -0.83 | -2.29 | -1.24 | -2.52 | -0.45 | -2.11 | -2.20 | -3.61 | -3.61 | -1.24 | -1.27 | -1.27 | -0.96 | -0.84 | -1.32 | -1.54 | -1.51 | -1.47 | -2.03 |
EPS (Diluted) | -430 | -0.57 | -0.65 | -0.62 | -0.88 | -0.83 | -2.29 | -1.24 | -2.52 | -0.45 | -2.11 | -2.20 | -3.61 | -3.61 | -1.24 | -1.27 | -1.27 | -0.96 | -0.84 | -1.32 | -1.54 | -1.51 | -1.47 | -2.03 |
EBITDA | -448K | -803K | -657K | -534K | -666K | -754K | -2.07M | -1.06M | -1.93M | -2.03M | -1.55M | -1.65M | -2.57M | -2.6M | -2.39M | -2.49M | -3.07M | -1.85M | -2.27M | -2.59M | 7.87M | -4.59M | -4.33M | -3.05M |
EBIT | -448K | -803K | -657K | -534K | -666K | -754K | -2.07M | -1.06M | -1.93M | -2.06M | -1.59M | -1.7M | -2.61M | -2.64M | -2.44M | -2.54M | -3.12M | -1.91M | -2.33M | -2.64M | 7.8M | -4.69M | -4.39M | -3.11M |
Depreciation & Amortization | n/a | n/a | 1.25K | 1.25K | n/a | n/a | 3K | 2K | 3K | 27K | 39K | 43K | 45K | 48K | 51K | 52K | 53K | 56K | 57K | 55K | 65K | 99K | 66K | 62K |
Add to Watchlist
Select watchlists to add or remove TTNP